This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
85% of accelerated approvals from 2010 to 2020 were for oncology indications. of approvals), cancer (35.6%), and other rare diseases (24.7%). Since then, accelerated Approval has shifted focus to oncology drugs.
Cardiovascular disease deaths in the US have increased by nearly 17% since 2010, and are among the reasons that life expectancy in the U.S. has also seen reversals in health improvements since 2010, partly due to increasing rates of obesity, high blood pressure, and high blood sugar. . is lower than in other high-income countries.
The company's lead gene therapies are idecabtagene vicleucel and elivaldogene autotemcel which were developed based on lentivirus vectors. ‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. Probiotical is a manufacturer of probiotics and synbiotics products.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. Encoded Therapeutics develops gene therapies for the treatment of severe genetic disorders.
I often tell people that working in pharma is often frustrated as they are incredibly process-driven and that matrix organizational structures lead to very slow decision-making. The average time it takes to fill an open position is 44 days, representing a 50-percent increase since 2010.
Patent volumes related to anti-influenza antibody compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies GSK 853 Unlock company profile Johnson & Johnson 706 Unlock company profile Mitsubishi Chemical Group 391 Unlock company profile C.
Patent volumes related to ssRNA virus peptides Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Johnson & Johnson 419 Unlock company profile GSK 419 Unlock company profile C. J&J develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. Exelixis is a biopharmaceutical company that focuses on the development and commercialisation of small molecules for the treatment of cancer.
Diabetes can lead to serious health complications like heart disease and stroke, so it’s important to take steps to avoid developing the disease if possible. According to an AARP study, in 2010 there were 7 potential caregivers for every person over 80. —and a silent killer. It doesn’t have to be this way.
Mike always battled weight issues, but since he went out on disability, he had gained more weight, leading to diabetes. An unhealthy diet is one of the leading risk factors for poor health and accounts for up to 45% of all deaths from these cardiometabolic diseases, the researchers noted. By 2010, it was up to 300 calories a day.
The company’s lead asset is NBTXR3, which is based on hafnium oxide nanoparticle that is designed to destroy tumors when activated by radiotherapy. ‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Before joining Siegfried in 2010, Wienand worked at the German specialty chemicals company Evonik Industries, Lonza highlighted. Wolfgang Wienand – leading the next chapter “Wolfgang brings a wealth of knowledge and experience to Lonza, complemented by his deep scientific and strategic expertise. billion.
A leading CB2 agonist, olorinab, displayed encouraging results when managing abdominal pain in irritable bowel syndrome (IBS) patients, but failed to meet the primary efficacy endpoints. Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010.
Dr. Badia’s journey from his immigrant roots to becoming a leading medical practitioner in Miami is truly inspiring. Learn how a childhood experience with his grandmother’s rheumatoid arthritis ignited his passion for hand surgery, leading to his extensive training at N.Y.U. and a transformative fellowship in Pittsburgh.
Patent volumes related to nucleoside chemical synthesis Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Gilead Sciences 544 Unlock company profile Johnson & Johnson 420 Unlock company profile Merck & Co 303 Unlock company profile Illumina 238 Unlock company profile F.
Moderna has filed patent infringement lawsuits alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty ® infringes patents Moderna filed between 2010 and 2016 covering its foundational messenger RNA (mRNA) technology.
He then had a one-year stint at Merck Research Laboratories as Director of Clinical Research for Clinical Hepatology before returning to Bristol Myers-Squibb from 2010-2015. ” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. Johnson & Johnson researches, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products.
Innovation S-curve for the pharmaceutical industry Periodontitis drugs is a notable innovation area in the pharmaceutical industry Periodontal diseases, which may lead to the damage of teeth or bone, are caused by infections and inflammation of the gums and bone that surround and support the teeth.
Patent volumes related to anti-viral antigen-based compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies GSK 993 Unlock company profile C. GSK is a healthcare company that focuses on developing, manufacturing and commercialising pharmaceuticals, vaccines, and consumer healthcare products.
This creates a need for flexible and scalable software tools for data processing, according to Robin Schmid from Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) and UC San Diego (CA, USA), project lead architect and one of the first authors of the paper.
Patent volumes related to zinc-finger nucleases Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Sangamo Therapeutics 793 Unlock company profile E. The company's lead asset involving this technology is isaralgagene civaparvovec (ST 920).
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. Akamis Bio, formerly PsiOxus Therapeutics, develops and discovers therapies for the treatment of cancer and other related diseases.
So the rst key skill is having a strategic mindset to lead the creation of strategies which support the mission and path-forward vision. Securing an education from MIT Sloan provides a great starting point as one has an opportunity to learn business concepts from a school which is part of the worlds leading research institution.
Patent volumes related to platinum-based cancer drug compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Bristol-Myers Squibb 281 Unlock company profile F. The company has filed several patents involving platinum compounds and developed drugs such as cisplatin and carboplatin.
Patent volumes related to lipase compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Novo Nordisk Foundation 340 Unlock company profile Sangamo Therapeutics 164 Unlock company profile Corteva 147 Unlock company profile Royal DSM 129 Unlock company profile E.
Patent volumes related to pyridine derivatives Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Bristol-Myers Squibb 146 Unlock company profile Corteva 135 Unlock company profile F.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. Immatics is a biopharmaceutical company focused on the development of T-cell immunotherapies to treat cancer.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. The company develops drugs for the management of pain.
Patent volumes related to oxazole derivatives-based cancer drug compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies F. Hoffmann-La Roche is the leading patent filer of oxazole derivatives-based cancer drug compositions.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. Seagen, formerly Seattle Genetics, develops and markets monoclonal antibody-based therapies for the treatment of cancer.
However, the reality is that traditional medicine has been the source of lead identification in modern drug discovery. Nature offers a realm of possibilities in drug discovery Alongside leads arising from traditional medicine, the natural world still has a lot to offer in drug discovery processes.
Patent volumes related to tetrapeptide derivatives space Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Amgen 317 Unlock company profile Bristol-Myers Squibb 281 Unlock company profile F.
SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. Say goodbye to all the supposed goodwill.
Since 2010, the UK has fallen from 4th to 98th place in overall trade balance in pharmaceuticals, due to fierce global competition, according to the MMIP. Over the same period, similar countries – including Ireland, France, and Germany – have been moving to boosting manufacturing productivity, output, and exports. .”
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to peptide nano-particle conjugates Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies F. Hoffmann-La Roche is the leading patent filer in the peptide nano-particle conjugates space. The company develops drugs and diagnostics to treat major diseases.
Patent volumes related to glycoside hydrolase-based drug compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Halozyme Therapeutics 260 Unlock company profile F.
Patent volumes related to monoclonal antibody conjugates for cancer treatment Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies F. Hoffmann-La Roche is the leading patent filer in monoclonal antibody conjugates for cancer treatment.
One thing I will say is that the pattern is that industry leaders are trending toward leading in social media. The last posting was in May 2010. Reading time: 2 – 4 minutes. Second and third place contenders in product categories both in medical devices and pharma tend to be lagging far behind in social media.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. The company has filed several patents for the production of induced pluripotent stem cells by using transcription factors.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to recombinant viral vector-based medicinal preparations Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies C.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content